Imaging sciences are not at a stage in which in vivo imaging can occur at near mum resolutions with image specificity at the physiological, cellular and molecular level. Although the molecular basis of many diseases are well defined, we do not have a full understanding of the mechanism by which they develop in vivo nor have we fully harnessed the potential for translating advances in molecular sciences into clinical practice imaging. Increased understanding of these areas and development of novel techniques is likely to provide new important directions in the earlier detection, molecular characterization and treatment of cancers. The proposed program at the Center for Molecular Imaging Research (CMIR) at Massachusetts General Hospital (MGH), Harvard Medial School, is organized to attack fundamental imaging at the cellular and molecular level. The principal research projects address imaging of specific enzymes in intact cellular and molecular level. The principal research projects address imaging of specific enzymes in intact tumor environments using smart optical probes (PI: R. Weissleder), in vivo imaging of angiogenesis and novel anti-angiogenic treatments (PI: a. Bogdanov), in vivo imaging of gene expression using new vectors and imaging of gene expression using new vectors and imaging marker gene S(PI: X.O. Breakefield) and in vivo tracking of progenitor and hematopoietic cells (PI: D.T. Scadden). These studies will be complemented by pilot projects dealing with viral delivery to tumors, developing high efficiency internalizing receptors for imaging probes, novel optical tomography systems for interrogating deep seated tumors and intracellular targeting and strategies for targeting of imaging probes to different intracellular components. The program also includes two scientific resources (a chemistry resource for the synthesis of a molecular imaging probes and a small animal imaging resource), a pilot project program and a career development program for multi-disciplinary training of scientists. A major goal of the Center in the long-term is the multi- disciplinary research approach and interaction with and involvement of basic research groups in the Harvard and other national medical areas, largely through collaborative experiments utilizing the core resources. The Center will thus serve as a regional and national resource to move research in the field ahead and recruit new investigators into molecular imaging research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA086355-03
Application #
6522610
Study Section
Special Emphasis Panel (ZCA1-SRRB-3 (J2))
Program Officer
Menkens, Anne E
Project Start
2000-08-09
Project End
2005-07-31
Budget Start
2002-08-15
Budget End
2003-07-31
Support Year
3
Fiscal Year
2002
Total Cost
$2,215,647
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Miller, Miles A; Weissleder, Ralph (2017) Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior. Adv Drug Deliv Rev 113:61-86
Engblom, Camilla; Pfirschke, Christina; Zilionis, Rapolas et al. (2017) Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils. Science 358:
Miller, Miles A; Askevold, Bjorn; Mikula, Hannes et al. (2017) Nano-palladium is a cellular catalyst for in vivo chemistry. Nat Commun 8:15906
Dubach, J Matthew; Kim, Eunha; Yang, Katherine et al. (2017) Quantitating drug-target engagement in single cells in vitro and in vivo. Nat Chem Biol 13:168-173
Vinegoni, Claudio; Fumene Feruglio, Paolo; Brand, Christian et al. (2017) Measurement of drug-target engagement in live cells by two-photon fluorescence anisotropy imaging. Nat Protoc 12:1472-1497
Iaconelli, Jonathan; Lalonde, Jasmin; Watmuff, Bradley et al. (2017) Lysine Deacetylation by HDAC6 Regulates the Kinase Activity of AKT in Human Neural Progenitor Cells. ACS Chem Biol 12:2139-2148
Arlauckas, Sean P; Garris, Christopher S; Kohler, Rainer H et al. (2017) In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy. Sci Transl Med 9:
Pucci, Ferdinando; Garris, Christopher; Lai, Charles P et al. (2016) SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions. Science 352:242-6
Roy, Jeremy; Kim, Bongki; Hill, Eric et al. (2016) Tyrosine kinase-mediated axial motility of basal cells revealed by intravital imaging. Nat Commun 7:10666
Pfirschke, Christina; Engblom, Camilla; Rickelt, Steffen et al. (2016) Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy. Immunity 44:343-54

Showing the most recent 10 out of 316 publications